| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |